As daily routines and social connections resume, consumers are placing renewed emphasis on personal hygiene—particularly in managing body odor, which remains a persistent concern. Staphylococcus hominis, a key culprit in body odor formation, is drawing increased attention in both product development and clinical research.
Manuka Oil is emerging as a powerful solution in this space, owing to its exceptional antibacterial activity against gram-positive bacteria—even at low concentrations. Studies, including Minimum Bactericidal Concentration (MBC) assays commissioned by Down Under Enterprises, have shown Manuka Oil’s remarkable efficacy against Staphylococcus hominis, Staphylococcus aureus, and Staphylococcus pyogenes. Notably, Manuka Oil demonstrates over 12-fold greater bactericidal potency than Tea Tree Oil against Propionibacterium acnes (0.102% versus 1.25%).
Sourced from the steam-distilled leaves of Leptospermum scoparium, native to New Zealand and Australia, Manuka Oil is still relatively new to the Personal Care market. However, insights from the MINTEL Global New Products Database (GNPD) confirm significant growth opportunities for its inclusion in Deodorant and Soap & Bath formulations.
Its remarkable performance is attributed to high levels of naturally occurring β-Triketones, chemical constituents unique to Manuka Oil and found in their highest concentrations here. For a full scientific breakdown—including comprehensive MIC and MBC test results—refer to our detailed White Paper.
No Comment